102 related articles for article (PubMed ID: 18315455)
1. Family conflict moderates response to pharmacological intervention in pediatric bipolar disorder.
Townsend LD; Demeter CA; Youngstrom E; Drotar D; Findling RL
J Child Adolesc Psychopharmacol; 2007 Dec; 17(6):843-52. PubMed ID: 18315455
[TBL] [Abstract][Full Text] [Related]
2. Divalproex sodium for pediatric mixed mania: a 6-month prospective trial.
Pavuluri MN; Henry DB; Carbray JA; Naylor MW; Janicak PG
Bipolar Disord; 2005 Jun; 7(3):266-73. PubMed ID: 15898964
[TBL] [Abstract][Full Text] [Related]
3. Preliminary study of relationships among measures of depressive symptoms in adolescents with bipolar disorder.
Patel NC; DelBello MP; Kowatch RA; Strakowski SM
J Child Adolesc Psychopharmacol; 2006 Jun; 16(3):327-35. PubMed ID: 16768640
[TBL] [Abstract][Full Text] [Related]
4. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.
Sussman N; Mullen J; Paulsson B; Vågerö M
J Affect Disord; 2007; 100 Suppl 1():S55-63. PubMed ID: 17383736
[TBL] [Abstract][Full Text] [Related]
5. Combination lithium and divalproex sodium in pediatric bipolarity.
Findling RL; McNamara NK; Gracious BL; Youngstrom EA; Stansbrey RJ; Reed MD; Demeter CA; Branicky LA; Fisher KE; Calabrese JR
J Am Acad Child Adolesc Psychiatry; 2003 Aug; 42(8):895-901. PubMed ID: 12874490
[TBL] [Abstract][Full Text] [Related]
6. Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial.
Sachs GS; Vanderburg DG; Karayal ON; Kolluri S; Bachinsky M; Cavus I
J Clin Psychiatry; 2012 Nov; 73(11):1412-9. PubMed ID: 23218157
[TBL] [Abstract][Full Text] [Related]
7. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
McIntyre RS; Konarski JZ; Jones M; Paulsson B
J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773
[TBL] [Abstract][Full Text] [Related]
8. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
Juruena MF; Ottoni GL; Machado-Vieira R; Carneiro RM; Weingarthner N; Marquardt AR; Fleig SS; Broilo L; Busnello EA
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):94-9. PubMed ID: 19007842
[TBL] [Abstract][Full Text] [Related]
9. Treatment of agitation and aggression in bipolar mania: efficacy of quetiapine.
Buckley PF; Paulsson B; Brecher M
J Affect Disord; 2007; 100 Suppl 1():S33-43. PubMed ID: 17376537
[TBL] [Abstract][Full Text] [Related]
10. Open-label prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric mania.
Pavuluri MN; Henry DB; Carbray JA; Sampson G; Naylor MW; Janicak PG
J Affect Disord; 2004 Oct; 82 Suppl 1():S103-11. PubMed ID: 15571784
[TBL] [Abstract][Full Text] [Related]
11. A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania.
Yatham LN; Vieta E; Young AH; Möller HJ; Paulsson B; Vågerö M
Int Clin Psychopharmacol; 2007 Jul; 22(4):212-20. PubMed ID: 17519644
[TBL] [Abstract][Full Text] [Related]
12. A one-year open-label trial of risperidone augmentation in lithium nonresponder youth with preschool-onset bipolar disorder.
Pavuluri MN; Henry DB; Carbray JA; Sampson GA; Naylor MW; Janicak PG
J Child Adolesc Psychopharmacol; 2006 Jun; 16(3):336-50. PubMed ID: 16768641
[TBL] [Abstract][Full Text] [Related]
13. A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder.
DelBello MP; Chang K; Welge JA; Adler CM; Rana M; Howe M; Bryan H; Vogel D; Sampang S; Delgado SV; Sorter M; Strakowski SM
Bipolar Disord; 2009 Aug; 11(5):483-93. PubMed ID: 19624387
[TBL] [Abstract][Full Text] [Related]
14. Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial.
Amsterdam JD; Wang CH; Shwarz M; Shults J
J Affect Disord; 2009 Jan; 112(1-3):219-30. PubMed ID: 18486235
[TBL] [Abstract][Full Text] [Related]
15. Relative effectiveness of adjunctive risperidone on manic and depressive symptoms in mixed mania.
Singh V; Bowden CL; Mintz J
Int Clin Psychopharmacol; 2013 Mar; 28(2):91-5. PubMed ID: 23238761
[TBL] [Abstract][Full Text] [Related]
16. Comparison of two anticonvulsants in a randomized, single-blind treatment of hypomanic symptoms in patients with bipolar disorder.
Suppes T; Kelly DI; Hynan LS; Snow DE; Sureddi S; Foster B; Curley E
Aust N Z J Psychiatry; 2007 May; 41(5):397-402. PubMed ID: 17464731
[TBL] [Abstract][Full Text] [Related]
17. Topiramate and divalproex in combination with risperidone for acute mania: a randomized open-label study.
Bahk WM; Shin YC; Woo JM; Yoon BH; Lee JS; Jon DI; Chung SK; Choi SK; Paik IH; Pae CU
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):115-21. PubMed ID: 15610953
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological response in juvenile bipolar disorder subtypes: A naturalistic retrospective examination.
Masi G; Perugi G; Millepiedi S; Mucci M; Pfanner C; Berloffa S; Pari C; Gagliano A; D'Amico F; Akiskal HS
Psychiatry Res; 2010 May; 177(1-2):192-8. PubMed ID: 20381170
[TBL] [Abstract][Full Text] [Related]
19. Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium.
Scheffer RE; Kowatch RA; Carmody T; Rush AJ
Am J Psychiatry; 2005 Jan; 162(1):58-64. PubMed ID: 15625202
[TBL] [Abstract][Full Text] [Related]
20. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
Vieta E; Owen R; Baudelet C; McQuade RD; Sanchez R; Marcus RN
Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
